Xueguan Lu. "Primary results from IChoice-02, a phase 2 trial of induction chemoimmunotherapy followed by response-adapted de-escalation of chemoradiation in HPV-associated oropharyngeal cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.6071